Clinical, endocrine, and molecular genetic findings in patients with 17β-hydroxysteroid dehydrogenase deficiency

Wiebke Twesten, Paul Martin Holterhus, Wolfgang G. Sippell, Michel Morlot, Heinz Schumacher, Bernd Schenk, Olaf Hiort*

*Korrespondierende/r Autor/-in für diese Arbeit
34 Zitate (Scopus)

Abstract

Mutations in the 17β-hydroxysteroid dehydrogenase (17β-HSD) type 3 gene are associated with the clinical findings of 17β-HSD deficiency. We investigated 5 patients of German descent with 46,XY karyotype and predominantly female phenotype. Androstenedione (A) and testosterone (T) levels in serum were determined before and after stimulation with human chorionic gonadotropin. DNA analysis of the whole coding region of the 17β- HSD type 3 gene was performed by PCR, single-strand conformation analysis, and direct sequencing. In all patients we found highly variable A and T levels before and after stimulation. However, the A-to-T ratio was abnormal in all cases suggestive of 17β-HSD deficiency. Molecular genetic analysis revealed mutations in all patients. We conclude that A and T levels may be highly variable in patients with 17β-HSD deficiency. Molecular genetic analysis of the 17β-HSD gene may support the diagnosis of this disorder. Copyright (C) 2000 S. Karger AG, Basel.

OriginalspracheEnglisch
ZeitschriftHormone Research
Jahrgang53
Ausgabenummer1
Seiten (von - bis)26-31
Seitenumfang6
ISSN0301-0163
DOIs
PublikationsstatusVeröffentlicht - 2000

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Clinical, endocrine, and molecular genetic findings in patients with 17β-hydroxysteroid dehydrogenase deficiency“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren